Rowena Gardner has a strong background in communication strategy, media relations, investor relations, advertising, marketing and internal communications within organisations of varying sizes and types (public (listed LSE/NASDAQ), private and not-for-profit), across a range of industry sectors.

Rowena has held various positions within the BioIndustry Association (BIA) including Chief Operating Officer and currently still holds the position of Company Secretary.

Prior to her work with the BIA she was Director of Corporate Communications at leading UK biotech company, Cambridge Antibody Technology (now part of AstraZeneca), where she built from scratch an integrated communications function following its Initial Public Offering in 1997.

Back to team